Anshul Badhwar, MD
Cardiovascular Disease (Cardiology) · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 11
- 2 carriers
- Office
- 1
- Since medical school
- 11 years
- University of North Carolina at Chapel Hill School of Medicine, 2015
Offices
1 location · Regents Univ of California UCSF · 276 clinicians in this group
Looking this up.
Hospitals listed: Marinhealth Medical Center · Novato Community Hospital. That is not proof they admit you there this week.
Plans that list them
11 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Badhwar’s office at (415) 476-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
11 of 11 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A181177 · Current
Licensed to practise in California · since 2022 · expires 2028-08-31 · University of North Carolina at Chapel Hill.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Marinhealth Medical CenterGreenbrae, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of MarinHealthPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.66 (3.59 to 7.73) · 1,505 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.177, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025
- Novato Community HospitalNovato, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Marinhealth Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.66 (3.59 to 7.73) · 1,505 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.177 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.83) · 1,056 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.72 to 1.36) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.34 (112.58 to 222.09) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 119 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 428 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.4 · 477 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 197 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,827 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.38) · 6,990 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.41) · 6,838 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 664 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.86 (1.4 to 4.33) · 1,436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.38 (3.68 to 17.08) · 705 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.38 (0.72 to 8.04) · 672 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.18 to 3.15) · 300 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0 to 1.25) · 5,550 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 76 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.396 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 427 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.3 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.3 · 494 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.9 · 499 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 435 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.4) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (7.8 to 16) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10.3 to 16.5) · 2,119 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 670 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,233 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Novato Community Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.06) · 213 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.4 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 25 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10 · 111 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.1 · 140 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.3 · 42 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 627 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,872 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,796 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.92 (0.5 to 5.33) · 505 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 317 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.2 (0.51 to 3.88) · 495 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.93 (0 to 17.29) · 323 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.88 (0.69 to 9.07) · 311 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.27) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.41 (0 to 1.49) · 1,320 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 143 cases | None | Apr 2023 – Mar 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 108 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.9 · 121 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.1 · 150 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 143 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 118 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 27 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.5 to 16.5) · 930 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 184 cases | No different | Jan 2024 – Dec 2024 |
What patients said (334 patients answered, 30% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 84% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$209,249
Medicare paid this office $209,249 for 1,310 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 385 | $63,365 | $101 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 146 | $26,600 | $99 |
| New patient visit (60+ min) | 153 | $25,421 | $166 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 98 | $14,050 | $140 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 268 | $13,800 | $51 |
See all 25 services
| Return visit (30+ min) | 385 | $63,365 | $101 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 146 | $26,600 | $99 |
| New patient visit (60+ min) | 153 | $25,421 | $166 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 98 | $14,050 | $140 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 268 | $13,800 | $51 |
| Long return visit (40+ min) | 69 | $9,820 | $133 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 377 | $8,333 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 133 | $7,727 | $57 |
| Critical care, first 30-74 minutes | 27 | $7,153 | $174 |
| Transitional care management services for problem of high complexity | 24 | $6,028 | $251 |
| Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | 100 | $5,252 | $24 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 54 | $3,195 | $56 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 205 | $3,041 | $11 |
| New patient visit (45+ min) | 17 | $2,406 | $142 |
| External shock to heart to regulate heart beat | 23 | $2,019 | $88 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 95 | $1,855 | $19 |
| Ultrasound of heart with probe in esophagus, with report | 14 | $1,237 | $88 |
| Heart rhythm recording of continous external ekg over 8-15 days | 70 | $756 | $11 |
| Ultrasound of heart blood flow, valves and chambers | 54 | $700 | $12 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 36 | $661 | $18 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | 44 | $641 | $12 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 26 | $281 | $11 |
| Ultrasound of heart blood flow, valves and chambers | 16 | $238 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 54 | $122 | $2 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 16 | $41 | $3 |
Who their Medicare patients are
1,310 Original Medicare patients in 2024. Average age 78 · Under 65 2% · 85 and older 20% · Women 46% · Also on Medicaid 14% · Health risk score 1.44. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 48% · Atrial fibrillation 44% · Heart failure 33% · Chronic kidney disease 28% · Diabetes 21% · Depression 21% · Cancer 19% · Stroke 17% · COPD 16% · Dementia 10%.
The office billed $1,311,166, Medicare allowed $283,511 and paid $209,249; for 3,458 services of 40 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,310 | 3,458 | 78 | 1.44 | $1,311,166 | $209,249 |
| 2023 | 976 | 2,208 | 77 | 1.37 | $1,086,932 | $180,172 |
| 2022 | 356 | 761 | 69 | 2.28 | $54,308 | $15,346 |
| 2021 | 53 | 71 | 70 | 1.92 | $8,761 | $2,845 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 23 services
| Return visit (30+ min) | 212 | $35,652 | $109 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 124 | $25,589 | $100 |
| Long return visit (40+ min) | 140 | $24,046 | $153 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 107 | $15,798 | $146 |
| New patient visit (60+ min) | 88 | $15,332 | $174 |
| New patient visit (45+ min) | 115 | $14,881 | $129 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 146 | $8,417 | $57 |
| Critical care, first 30-74 minutes | 26 | $8,108 | $198 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 109 | $6,556 | $58 |
| Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | 74 | $4,962 | $24 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 48 | $3,201 | $67 |
| External shock to heart to regulate heart beat | 22 | $2,026 | $92 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 83 | $1,738 | $20 |
| Ultrasound of heart with probe in esophagus, with report | 17 | $1,521 | $89 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 63 | $966 | $13 |
| Heart rhythm recording of continous external ekg over 8-15 days | 63 | $691 | $11 |
| Ultrasound of heart blood flow, valves and chambers | 48 | $675 | $14 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 31 | $567 | $18 |
| Ultrasound of heart blood flow, valves and chambers | 20 | $300 | $15 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 24 | $256 | $11 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 11 | $232 | $21 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 49 | $120 | $2 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 20 | $52 | $3 |
2022: 5 services
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 330 | $4,048 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 64 | $2,908 | $44 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 23 | $2,135 | $93 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,765 | $126 |
| Return visit (30+ min) | 12 | $1,111 | $74 |
2021: 2 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 18 | $1,140 | $63 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 30 | $296 | $8 |
Medicaid work
$7,733 in 2024
Medicaid paid $7,733 for 155 billed services this clinician did in 2024, up to 22 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 61 | $4,226 |
| Return visit (30+ min) | 69 | $2,895 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 25 | $611 |
| 2024 | 155 | 3 | 22 | $7,733 |
| 2023 | 45 | 2 | 15 | $2,240 |
| 2022 | 4,019 | 3 | 298 | $36,571 |
| 2021 | 292 | 2 | 73 | $2,698 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 31 | $1,509 |
| Return visit (30+ min) | 14 | $731 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 3,741 | $19,765 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 265 | $16,293 |
| Return visit (30+ min) | 13 | $514 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 50 | $1,449 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 242 | $1,249 |
Drugs they prescribed that Part D paid
$459,521
Pharmacies billed $459,521 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,447) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
2,025 generic and 422 brand-name prescriptions · $459,521 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 150 | $185,611 | $1,237 |
| Xarelto | 51 | $66,363 | $1,301 |
| Repatha Sureclick | 54 | $59,563 | $1,103 |
| Entresto | 42 | $42,424 | $1,010 |
| Farxiga | 35 | $35,450 | $1,013 |
See all 36 drugs
| Eliquis | 150 | $185,611 | $1,237 |
| Xarelto | 51 | $66,363 | $1,301 |
| Repatha Sureclick | 54 | $59,563 | $1,103 |
| Entresto | 42 | $42,424 | $1,010 |
| Farxiga | 35 | $35,450 | $1,013 |
| Vascepa | 11 | $7,433 | $676 |
| Metoprolol | 243 | $2,880 | $12 |
| Dabigatran Etexilate | 12 | $2,832 | $236 |
| Rosuvastatin | 186 | $2,739 | $15 |
| Ezetimibe | 64 | $2,465 | $39 |
| Atorvastatin | 226 | $2,340 | $10 |
| Losartan | 201 | $2,134 | $11 |
| Icosapent Ethyl | 11 | $1,605 | $146 |
| Amlodipine Besylate | 198 | $1,408 | $7 |
| Valsartan | 29 | $856 | $30 |
| Furosemide | 98 | $823 | $8 |
| Olmesartan Medoxomil | 40 | $742 | $19 |
| Propranolol | 29 | $569 | $20 |
| Spironolactone | 45 | $520 | $12 |
| Clopidogrel | 26 | $517 | $20 |
| Irbesartan | 17 | $513 | $30 |
| Sotalol | 18 | $509 | $28 |
| Diltiazem 24hr Er (Cd) | 21 | $505 | $24 |
| Isosorbide Mononitrate Er | 17 | $430 | $25 |
| Metoprolol | 60 | $430 | $7 |
| Hydrochlorothiazide | 93 | $351 | $4 |
| Lisinopril | 49 | $350 | $7 |
| Hydralazine | 29 | $340 | $12 |
| Potassium Chloride | 25 | $324 | $13 |
| Warfarin | 12 | $279 | $23 |
| Pravastatin | 15 | $266 | $18 |
| Carvedilol | 37 | $264 | $7 |
| Propranolol Hcl Er | 16 | $251 | $16 |
| Simvastatin | 37 | $218 | $6 |
| Benazepril | 13 | $188 | $14 |
| Losartan-Hydrochlorothiazide | 12 | $83 | $7 |
Year by year
| 2024 | 2,447 | 448 | 0% (0) | 17% | $459,521 |
| 2023 | 1,048 | 306 | None | 15% | $174,873 |
| 2022 | 340 | 93 | 0% (0) | 27% | $86,839 |
| 2021 | 62 | 30 | 0% (0) | None | $5,174 |
| 2020 | 33 | None | 0% (0) | None | $3,797 |
| 2018 | 24 | None | 0% (0) | None | $15,419 |
| 2017 | 33 | 11 | 0% (0) | None | $1,827 |
| 2016 | 38 | 13 | 0% (0) | None | $4,071 |
| 2015 | 32 | 12 | 0% (0) | None | $1,452 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Eliquis | 83 | $78,271 | $943 |
| Repatha Sureclick | 20 | $20,181 | $1,009 |
| Xarelto | 14 | $17,734 | $1,267 |
| Entresto | 15 | $16,266 | $1,084 |
| Rosuvastatin | 94 | $2,576 | $27 |
| Metoprolol | 116 | $2,109 | $18 |
| Ezetimibe | 33 | $1,606 | $49 |
| Atorvastatin | 94 | $1,135 | $12 |
| Amlodipine Besylate | 104 | $677 | $7 |
| Diltiazem 24hr Er (Cd) | 15 | $604 | $40 |
| Losartan | 43 | $502 | $12 |
| Spironolactone | 38 | $435 | $11 |
| Clopidogrel | 22 | $361 | $16 |
| Lisinopril | 30 | $354 | $12 |
| Furosemide | 42 | $273 | $6 |
| Metoprolol | 42 | $213 | $5 |
| Benazepril | 13 | $144 | $11 |
| Simvastatin | 11 | $137 | $12 |
| Carvedilol | 20 | $130 | $7 |
| Hydrochlorothiazide | 22 | $74 | $3 |
2022: 10 drugs
| Entresto | 39 | $29,771 | $763 |
| Eliquis | 24 | $24,024 | $1,001 |
| Farxiga | 17 | $21,280 | $1,252 |
| Metoprolol | 49 | $1,218 | $25 |
| Atorvastatin | 29 | $531 | $18 |
| Furosemide | 25 | $249 | $10 |
| Losartan | 16 | $218 | $14 |
| Amlodipine Besylate | 19 | $197 | $10 |
| Isosorbide Mononitrate Er | 15 | $145 | $10 |
| Carvedilol | 13 | $115 | $9 |
2021: 1 drug
| Carvedilol | 13 | $77 | $6 |
Money from drug and device companies
$48 in 2025
| 2025 | 3 | 3 | None | $48 |
| 2024 | 2 | 4 | None | $150 |
| 2022 | 4 | 5 | None | $115 |
| 2021 | 5 | 11 | None | $182 |
| 2020 | 3 | 3 | None | $57 |
| 2019 | 5 | 7 | None | $110 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| B. Braun Interventional Systems | Cp Stent | $17 | 1 payment
|
| Heartflow | Ffrct | $17 | 1 payment
|
| Cardiva Medical | Cardiva Vascade Mvp Vvcs 6-12f | $14 | 1 payment
|
See all 3 published payments
| B. Braun Interventional Systems | Meals · 2025-11-06 | Cp Stent | $17 |
| Heartflow | Meals · 2025-05-27 | Ffrct | $17 |
| Cardiva Medical | Meals · 2025-01-16 | Cardiva Vascade Mvp Vvcs 6-12f | $14 |
See earlier years (2024, 2022, 2021, 2020, 2019)
2024: $150
| Heartflow | Ffrct | $135 | 3 payments
|
| Cardiva Medical | Cardiva Vascade 6/7f Vcs | $16 | 1 payment
|
2022: $115
| Novartis Pharmaceuticals | Entresto | $38 | 2 payments
|
| Lantheus Medical Imaging | Definity | $34 | 1 payment
|
| Amgen | Repatha | $25 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $19 | 1 payment
|
2021: $182
| Amgen | Repatha | $58 | 3 payments
|
| Pfizer | Eliquis | $46 | 3 payments
|
| Merck Sharp & Dohme | Verquvo | $32 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $31 | 2 payments
|
| Alexion Pharmaceuticals | Andexxa | $16 | 1 payment
|
2020: $57
| Lantheus Medical Imaging | Definity | $23 | 1 payment
|
| Medtronic Vascular | In.Pact Admiral | $18 | 1 payment
|
| Amgen | Repatha | $16 | 1 payment
|
2019: $110
| Medtronic Vascular | Heartware Hvad | $46 | 3 payments
|
| Genzyme | Fabry-Disease | $23 | 1 payment
|
| Lantheus Medical Imaging | Definity | $17 | 1 payment
|
| Pfizer | Vyndaqel | $13 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $11 | 1 payment
|
Professional record
- NPI
- 1710365614
- Licence
- CA A181177, NY 312447California A181177: Current · expires 2028-08-31
- Trained
- University of North Carolina at Chapel Hill School of Medicine, 2015 · 11 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 2 Bon Air Rd Ste 100, Larkspur, CA, 94939
- NPI first listed
- 2015-05-12
- NPI last updated
- 2023-05-17
- NPI record certified
- 2023-01-20
This is when the NPI record was last certified, not a medical board exam.